Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance.
- NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_assertion description "[In addition, Cdk4(R24C/R24C) mice showed extraordinary susceptibility to carcinogens and developed papillomas within the first 8 to 10 weeks following cutaneous application of the carcinogens 9,10-di-methyl-1,2-benz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance.
- NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_assertion evidence source_evidence_literature NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance.
- NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_assertion SIO_000772 11756559 NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance.
- NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_assertion wasDerivedFrom befree-20150227 NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance.
- NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_assertion wasGeneratedBy ECO_0000203 NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP301369.RARhe9tFyf_mFrCYlLyGb8d5ZCJN3rzaS6e82TnT7nHpg130_provenance.